ACE and colorectal cancer: A meta-analysis of 7 observational studies reported a protective association of ACE inhibitor use with colorectal cancer risk (OR 0.81 95% CI 0.70 to 0.92), though with substantial heterogeneity across studies (I2 = 71.1%) [14].